Annual Net Income
-$599.49 M
-$394.22 M-192.04%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual net profit is -$599.49 million, with the most recent change of -$394.22 million (-192.04%) on September 30, 2024.
- During the last 3 years, ARWR annual net income has fallen by -$458.64 million (-325.63%).
- ARWR annual net income is now -981.93% below its all-time high of $67.97 million, reached on September 30, 2019.
Performance
ARWR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$170.54 M
+$257.00 K+0.15%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly net profit is -$170.54 million, with the most recent change of +$257.00 thousand (+0.15%) on September 30, 2024.
- Over the past year, ARWR quarterly net income has dropped by -$45.24 million (-36.10%).
- ARWR quarterly net income is now -450.36% below its all-time high of $48.67 million, reached on March 31, 2023.
Performance
ARWR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$599.49 M
-$60.86 M-11.30%
September 30, 2024
Summary
- As of February 7, 2025, ARWR TTM net profit is -$599.49 million, with the most recent change of -$60.86 million (-11.30%) on September 30, 2024.
- Over the past year, ARWR TTM net income has dropped by -$128.70 million (-27.34%).
- ARWR TTM net income is now -981.93% below its all-time high of $67.98 million, reached on September 30, 2019.
Performance
ARWR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ARWR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -192.0% | -36.1% | -27.3% |
| 3 y3 years | -325.6% | -169.1% | -325.6% |
| 5 y5 years | -981.9% | -169.1% | -325.6% |
ARWR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -325.6% | at low | -450.4% | +0.1% | -436.2% | at low |
| 5 y | 5-year | -981.9% | at low | -450.4% | +0.1% | -1225.5% | at low |
| alltime | all time | -981.9% | at low | -450.4% | +0.1% | -981.9% | at low |
Arrowhead Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$599.49 M(+192.0%) | -$170.54 M(-0.2%) | -$599.49 M(+11.3%) |
| Jun 2024 | - | -$170.79 M(+36.3%) | -$538.64 M(+14.4%) |
| Mar 2024 | - | -$125.30 M(-5.7%) | -$470.79 M(+58.6%) |
| Dec 2023 | - | -$132.86 M(+21.1%) | -$296.81 M(+44.6%) |
| Sep 2023 | -$205.28 M(+16.6%) | -$109.68 M(+6.5%) | -$205.28 M(+13.3%) |
| Jun 2023 | - | -$102.95 M(-311.5%) | -$181.11 M(+20.6%) |
| Mar 2023 | - | $48.67 M(-217.8%) | -$150.21 M(-2.8%) |
| Dec 2022 | - | -$41.33 M(-51.7%) | -$154.52 M(-12.2%) |
| Sep 2022 | -$176.06 M(+25.0%) | -$85.51 M(+18.7%) | -$176.06 M(+14.4%) |
| Jun 2022 | - | -$72.05 M(-262.4%) | -$153.93 M(+37.7%) |
| Mar 2022 | - | $44.37 M(-170.6%) | -$111.80 M(-38.9%) |
| Dec 2021 | - | -$62.87 M(-0.8%) | -$182.99 M(+29.9%) |
| Sep 2021 | -$140.85 M(+66.6%) | -$63.37 M(+111.8%) | -$140.85 M(+11.9%) |
| Jun 2021 | - | -$29.92 M(+11.6%) | -$125.91 M(+14.9%) |
| Mar 2021 | - | -$26.82 M(+29.4%) | -$109.59 M(+6.8%) |
| Dec 2020 | - | -$20.73 M(-57.2%) | -$102.61 M(+21.4%) |
| Sep 2020 | -$84.55 M(-224.4%) | -$48.43 M(+255.8%) | -$84.55 M(+246.3%) |
| Jun 2020 | - | -$13.61 M(-31.4%) | -$24.41 M(-356.1%) |
| Mar 2020 | - | -$19.84 M(+642.1%) | $9.53 M(-82.1%) |
| Dec 2019 | - | -$2.67 M(-122.8%) | $53.26 M(-21.6%) |
| Sep 2019 | $67.97 M(-224.8%) | $11.71 M(-42.4%) | $67.98 M(+49.4%) |
| Jun 2019 | - | $20.34 M(-14.9%) | $45.51 M(+375.7%) |
| Mar 2019 | - | $23.90 M(+98.5%) | $9.57 M(-132.7%) |
| Dec 2018 | - | $12.04 M(-211.9%) | -$29.21 M(-46.3%) |
| Sep 2018 | -$54.45 M(+58.4%) | -$10.76 M(-31.0%) | -$54.45 M(+0.1%) |
| Jun 2018 | - | -$15.61 M(+4.8%) | -$54.42 M(+22.8%) |
| Mar 2018 | - | -$14.88 M(+12.8%) | -$44.33 M(+24.9%) |
| Dec 2017 | - | -$13.20 M(+23.0%) | -$35.49 M(+3.2%) |
| Sep 2017 | -$34.38 M(-57.9%) | -$10.73 M(+94.4%) | -$34.38 M(-25.0%) |
| Jun 2017 | - | -$5.52 M(-8.7%) | -$45.87 M(-23.3%) |
| Mar 2017 | - | -$6.04 M(-50.0%) | -$59.77 M(-19.8%) |
| Dec 2016 | - | -$12.09 M(-45.6%) | -$74.54 M(-8.8%) |
| Sep 2016 | -$81.72 M(-11.1%) | -$22.22 M(+14.4%) | -$81.72 M(-3.0%) |
| Jun 2016 | - | -$19.42 M(-6.7%) | -$84.24 M(+4.3%) |
| Mar 2016 | - | -$20.82 M(+8.1%) | -$80.76 M(-8.9%) |
| Dec 2015 | - | -$19.26 M(-22.1%) | -$88.63 M(-3.6%) |
| Sep 2015 | -$91.94 M(+56.8%) | -$24.74 M(+55.3%) | -$91.94 M(+2.6%) |
| Jun 2015 | - | -$15.94 M(-44.4%) | -$89.63 M(+5.0%) |
| Mar 2015 | - | -$28.68 M(+27.1%) | -$85.32 M(+20.9%) |
| Dec 2014 | - | -$22.58 M(+0.6%) | -$70.58 M(+20.4%) |
| Sep 2014 | -$58.63 M(+88.3%) | -$22.43 M(+92.9%) | -$58.63 M(+17.5%) |
| Jun 2014 | - | -$11.63 M(-16.6%) | -$49.89 M(+12.5%) |
| Mar 2014 | - | -$13.94 M(+31.2%) | -$44.34 M(+19.3%) |
| Dec 2013 | - | -$10.63 M(-22.4%) | -$37.16 M(+19.3%) |
| Sep 2013 | -$31.14 M(+47.4%) | -$13.69 M(+125.2%) | -$31.14 M(+36.8%) |
| Jun 2013 | - | -$6.08 M(-10.0%) | -$22.76 M(-7.8%) |
| Mar 2013 | - | -$6.76 M(+46.5%) | -$24.68 M(+6.1%) |
| Dec 2012 | - | -$4.61 M(-13.2%) | -$23.25 M(+10.1%) |
| Sep 2012 | -$21.13 M | -$5.31 M(-33.5%) | -$21.13 M(+13.6%) |
| Jun 2012 | - | -$7.99 M(+49.8%) | -$18.59 M(+49.7%) |
| Mar 2012 | - | -$5.34 M(+114.7%) | -$12.42 M(+197.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | - | -$2.49 M(-10.5%) | -$4.18 M(+33.5%) |
| Sep 2011 | -$3.13 M(-45.8%) | -$2.78 M(+52.6%) | -$3.13 M(+32.8%) |
| Jun 2011 | - | -$1.82 M(-162.6%) | -$2.36 M(+159.6%) |
| Mar 2011 | - | $2.91 M(-302.1%) | -$907.70 K(-84.0%) |
| Dec 2010 | - | -$1.44 M(-28.3%) | -$5.67 M(-1.9%) |
| Sep 2010 | -$5.77 M(-70.1%) | -$2.00 M(+440.0%) | -$5.77 M(-20.1%) |
| Jun 2010 | - | -$371.10 K(-80.0%) | -$7.23 M(-23.0%) |
| Mar 2010 | - | -$1.85 M(+20.0%) | -$9.39 M(-26.8%) |
| Dec 2009 | - | -$1.54 M(-55.3%) | -$12.82 M(-33.6%) |
| Sep 2009 | -$19.31 M(-28.7%) | -$3.46 M(+36.8%) | -$19.31 M(-21.2%) |
| Jun 2009 | - | -$2.53 M(-52.2%) | -$24.51 M(-16.9%) |
| Mar 2009 | - | -$5.29 M(-34.1%) | -$29.48 M(-1.4%) |
| Dec 2008 | - | -$8.03 M(-7.3%) | -$29.89 M(+10.3%) |
| Sep 2008 | -$27.09 M(-9.5%) | -$8.66 M(+15.4%) | -$27.09 M(+4.2%) |
| Jun 2008 | - | -$7.50 M(+31.7%) | -$26.00 M(-16.1%) |
| Mar 2008 | - | -$5.69 M(+8.8%) | -$30.98 M(-1.5%) |
| Dec 2007 | - | -$5.23 M(-30.9%) | -$31.46 M(+5.1%) |
| Sep 2007 | -$29.93 M(+57.6%) | -$7.57 M(-39.3%) | -$29.93 M(+4.1%) |
| Jun 2007 | - | -$12.48 M(+102.1%) | -$28.76 M(+41.0%) |
| Mar 2007 | - | -$6.17 M(+66.5%) | -$20.40 M(+5.0%) |
| Dec 2006 | - | -$3.71 M(-42.1%) | -$19.42 M(+3.0%) |
| Sep 2006 | -$19.00 M(+177.1%) | -$6.41 M(+55.8%) | -$18.85 M(+23.1%) |
| Jun 2006 | - | -$4.11 M(-20.9%) | -$15.32 M(+8.1%) |
| Mar 2006 | - | -$5.19 M(+65.6%) | -$14.17 M(+69.5%) |
| Dec 2005 | - | -$3.14 M(+9.2%) | -$8.36 M(+23.2%) |
| Sep 2005 | -$6.85 M(+171.1%) | -$2.87 M(-3.1%) | -$6.79 M(+25.2%) |
| Jun 2005 | - | -$2.97 M(-581.5%) | -$5.42 M(+75.3%) |
| Mar 2005 | - | $615.90 K(-139.4%) | -$3.09 M(-20.4%) |
| Dec 2004 | - | -$1.56 M(+3.6%) | -$3.88 M(+53.7%) |
| Sep 2004 | -$2.53 M(+2555.7%) | -$1.51 M(+136.3%) | -$2.53 M(+177.2%) |
| Jun 2004 | - | -$638.20 K(+262.8%) | -$911.90 K(+178.7%) |
| Mar 2004 | - | -$175.90 K(-14.6%) | -$327.20 K(+27.8%) |
| Dec 2003 | - | -$205.90 K(-290.5%) | -$256.10 K(+168.7%) |
| Sep 2003 | -$95.20 K(-61.3%) | $108.10 K(-302.1%) | -$95.30 K(-66.9%) |
| Jun 2003 | - | -$53.50 K(-49.0%) | -$288.10 K(-10.7%) |
| Mar 2003 | - | -$104.80 K(+132.4%) | -$322.70 K(+41.5%) |
| Dec 2002 | - | -$45.10 K(-46.8%) | -$228.10 K(-7.4%) |
| Sep 2002 | -$246.20 K(+32.5%) | -$84.70 K(-3.9%) | -$246.30 K(+10.7%) |
| Jun 2002 | - | -$88.10 K(+763.7%) | -$222.50 K(+33.2%) |
| Mar 2002 | - | -$10.20 K(-83.9%) | -$167.00 K(-19.8%) |
| Dec 2001 | - | -$63.30 K(+3.9%) | -$208.20 K(+12.1%) |
| Sep 2001 | -$185.80 K(+35.0%) | -$60.90 K(+86.8%) | -$185.70 K(+106.3%) |
| Jun 2001 | - | -$32.60 K(-36.6%) | -$90.00 K(-21.7%) |
| Mar 2001 | - | -$51.40 K(+26.0%) | -$115.00 K(-2.3%) |
| Dec 2000 | - | -$40.80 K(-217.2%) | -$117.70 K(-14.5%) |
| Sep 2000 | -$137.60 K(-123.2%) | $34.80 K(-160.4%) | -$137.60 K(-20.2%) |
| Jun 2000 | - | -$57.60 K(+6.5%) | -$172.40 K(+50.2%) |
| Mar 2000 | - | -$54.10 K(-10.9%) | -$114.80 K(+89.1%) |
| Dec 1999 | - | -$60.70 K | -$60.70 K |
| Sep 1999 | $593.00 K(-459.4%) | - | - |
| Sep 1998 | -$165.00 K(-80.7%) | - | - |
| Sep 1997 | -$854.50 K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual net profit?
- What is the all time high annual net income for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual net income year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly net income year-on-year change?
- What is Arrowhead Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM net income year-on-year change?
What is Arrowhead Pharmaceuticals annual net profit?
The current annual net income of ARWR is -$599.49 M
What is the all time high annual net income for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual net profit is $67.97 M
What is Arrowhead Pharmaceuticals annual net income year-on-year change?
Over the past year, ARWR annual net profit has changed by -$394.22 M (-192.04%)
What is Arrowhead Pharmaceuticals quarterly net profit?
The current quarterly net income of ARWR is -$170.54 M
What is the all time high quarterly net income for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly net profit is $48.67 M
What is Arrowhead Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ARWR quarterly net profit has changed by -$45.24 M (-36.10%)
What is Arrowhead Pharmaceuticals TTM net profit?
The current TTM net income of ARWR is -$599.49 M
What is the all time high TTM net income for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM net profit is $67.98 M
What is Arrowhead Pharmaceuticals TTM net income year-on-year change?
Over the past year, ARWR TTM net profit has changed by -$128.70 M (-27.34%)